Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis—A possible target for novel therapies?
Authors:
- Jürgen SchauberJSJürgen Schauber
- 1 June 2010
- journal article
- review article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 58 (3) , 171-176
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- PsoriasisNew England Journal of Medicine, 2009
- Angiogenesis drives psoriasis pathogenesisInternational Journal of Experimental Pathology, 2009
- Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasisBritish Journal of Dermatology, 2009
- Pathogenesis and therapy of psoriasisNature, 2007
- Observations of Psoriasis in the Absence of Therapeutic Intervention Identifies Two Unappreciated Morphologic Variants, Thin-Plaque and Thick-Plaque Psoriasis, and their Associated PhenotypesJournal of Investigative Dermatology, 2006
- Innate and adaptive immunity and the pathophysiology of psoriasisJournal of the American Academy of Dermatology, 2006
- Understanding the IL-23–IL-17 immune pathwayTrends in Immunology, 2006
- Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell ProliferationThe Journal of Immunology, 2005
- The immunologic basis for the treatment of psoriasis with new biologic agentsJournal of the American Academy of Dermatology, 2002
- T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted productsEuropean Journal of Immunology, 1994